Cargando…

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study

BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Changfa, Xu, Xiaoqian, Zhao, Xuelian, Hu, Shangying, Qiao, Youlin, Zhang, Yong, Hutubessy, Raymond, Basu, Partha, Broutet, Nathalie, Jit, Mark, Zhao, Fanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927373/
https://www.ncbi.nlm.nih.gov/pubmed/33653331
http://dx.doi.org/10.1186/s12916-021-01930-9
_version_ 1783659655009927168
author Xia, Changfa
Xu, Xiaoqian
Zhao, Xuelian
Hu, Shangying
Qiao, Youlin
Zhang, Yong
Hutubessy, Raymond
Basu, Partha
Broutet, Nathalie
Jit, Mark
Zhao, Fanghui
author_facet Xia, Changfa
Xu, Xiaoqian
Zhao, Xuelian
Hu, Shangying
Qiao, Youlin
Zhang, Yong
Hutubessy, Raymond
Basu, Partha
Broutet, Nathalie
Jit, Mark
Zhao, Fanghui
author_sort Xia, Changfa
collection PubMed
description BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-effectiveness of tailored actions. METHODS: A validated hybrid model was used to assess the costs and benefits of alternative strategies combining human papillomavirus vaccination, cervical screening, and treatment of pre-invasive lesions and invasive cancer for females with different immunization history. All Chinese females living or projected to be born during 2015–2100, under projected trends in aging, urbanization, and sexual activity, were considered. Optimal strategies were determined by cost-effectiveness efficiency frontiers. Primary outcomes were cervical cancer cases and deaths averted and incremental cost-effectiveness ratios (ICERs). We employed a lifetime horizon from a societal perspective. One-way and probabilistic sensitivity analyses evaluate model uncertainty. RESULTS: The optimal pathway represents an integration of multiple tailored strategies from females with different immunization history. If China adopts the optimal pathway, the age-standardized incidence of cervical cancer is predicted to decrease to fewer than four new cases per 100,000 women (i.e., elimination) by 2047 (95% confidence interval 2043 to 2050). Compared to the status quo, the optimal pathway would avert a total of 7,509,192 (6,922,744 to 8,359,074) cervical cancer cases and 2,529,873 (2,366,826 to 2,802,604) cervical cancer deaths in 2021–2100, with the discounted ICER being $− 339 (− 687 to − 79) per quality-adjusted life-year. CONCLUSIONS: By adopting an optimal pathway from 2021 (namely, the year of the first Chinese Centennial Goals) onwards, cervical cancer could be eliminated by the late 2040s (namely, ahead of the second Chinese Centennial Goals) while saving net economic costs in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01930-9.
format Online
Article
Text
id pubmed-7927373
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79273732021-03-03 Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study Xia, Changfa Xu, Xiaoqian Zhao, Xuelian Hu, Shangying Qiao, Youlin Zhang, Yong Hutubessy, Raymond Basu, Partha Broutet, Nathalie Jit, Mark Zhao, Fanghui BMC Med Research Article BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-effectiveness of tailored actions. METHODS: A validated hybrid model was used to assess the costs and benefits of alternative strategies combining human papillomavirus vaccination, cervical screening, and treatment of pre-invasive lesions and invasive cancer for females with different immunization history. All Chinese females living or projected to be born during 2015–2100, under projected trends in aging, urbanization, and sexual activity, were considered. Optimal strategies were determined by cost-effectiveness efficiency frontiers. Primary outcomes were cervical cancer cases and deaths averted and incremental cost-effectiveness ratios (ICERs). We employed a lifetime horizon from a societal perspective. One-way and probabilistic sensitivity analyses evaluate model uncertainty. RESULTS: The optimal pathway represents an integration of multiple tailored strategies from females with different immunization history. If China adopts the optimal pathway, the age-standardized incidence of cervical cancer is predicted to decrease to fewer than four new cases per 100,000 women (i.e., elimination) by 2047 (95% confidence interval 2043 to 2050). Compared to the status quo, the optimal pathway would avert a total of 7,509,192 (6,922,744 to 8,359,074) cervical cancer cases and 2,529,873 (2,366,826 to 2,802,604) cervical cancer deaths in 2021–2100, with the discounted ICER being $− 339 (− 687 to − 79) per quality-adjusted life-year. CONCLUSIONS: By adopting an optimal pathway from 2021 (namely, the year of the first Chinese Centennial Goals) onwards, cervical cancer could be eliminated by the late 2040s (namely, ahead of the second Chinese Centennial Goals) while saving net economic costs in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01930-9. BioMed Central 2021-03-03 /pmc/articles/PMC7927373/ /pubmed/33653331 http://dx.doi.org/10.1186/s12916-021-01930-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Xia, Changfa
Xu, Xiaoqian
Zhao, Xuelian
Hu, Shangying
Qiao, Youlin
Zhang, Yong
Hutubessy, Raymond
Basu, Partha
Broutet, Nathalie
Jit, Mark
Zhao, Fanghui
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title_full Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title_fullStr Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title_full_unstemmed Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title_short Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
title_sort effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927373/
https://www.ncbi.nlm.nih.gov/pubmed/33653331
http://dx.doi.org/10.1186/s12916-021-01930-9
work_keys_str_mv AT xiachangfa effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT xuxiaoqian effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT zhaoxuelian effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT hushangying effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT qiaoyoulin effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT zhangyong effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT hutubessyraymond effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT basupartha effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT broutetnathalie effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT jitmark effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy
AT zhaofanghui effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy